click below
click below
Normal Size Small Size show me how
Pharm
Meds affecting Nervous System
| Question | Answer |
|---|---|
| Action of Cholinesterase Inhibitors | Prevent cholinesterase from inactivating acetylcholine = amt of Ach available at receptor site |
| Prostigmin increases muscle _____and reverses nondepolarizing blocking agents following____ | strength, surgery |
| A Cholinergic crisis | increased muscarinic stimulation and depressed respiration |
| Side/Adverse Effects of Cholinesterase Inhibitors | Increased muscarine stimulation = treated with atropine and Cholinergic crisis |
| Contraindications/precautions of Cholinesterase Inhibitors | Contraindicated in pts with obstruction of GI system |
| Med/Food Interactions of Cholinesterase Inhibitors | Atropine – treatment of Prostigmin toxicity, Tubocurarine – reverses neuromuscular blockade after surgery, Succinylcholine – increases neuromuscular blockage |
| Interventions of Cholinesterase Inhibitors | Dosing is individualized |
| Prototype Medications of Cholinesterase Inhibitors | Prostigmin, physostigmine |
| Action of Neuromuscular Blocking Agents | Block Ach at neuromuscular junction = muscle relaxation and hypotension; Do no cross blood-brain barrier |
| Therapeutic Action of Neuromuscular Blocking Agents | Used as adjuncts to general anesthesia = muscle relaxation; Used to diagnose myasthenia gravis |
| Side/Adverse Effects of Neuromuscular Blocking Agents | Respiratory arrest from paralyzed respiratory muscles – have equipment ready for resuscitation; Hypotension from histamine release |
| Contraindications/precautions of Neuromuscular Blocking Agents | Anectine is contraindicated in pts with risk of hyperkalemia |
| Med/Food Interactions of Neuromuscular Blocking Agents | General Anes– dose of tubocurarine should be reduced, Aminoglycosides &tetracycline increase effects of neuromuscular blocks , cholinesterase inhibitors – decrease effects of nondepolarizing blockers and increase effects of depolarizing neurotransmitters |
| Interventions of Neuromuscular Blocking Agents | Monitor cardiac and respiratory function |
| Prototype Medications of Neuromuscular Blocking Agents | Nondepolarizing neuromuscular blocker – Tubarine; Depolarizing neuromuscular blocker – succinylcholine |
| Action of Levodopa (Dopaminergic) | Levodopa crosses blood-brain barrier which stimulates dopamine receptors |
| Carbidopa adds to levodopa by | inhibiting the conversion of levodopa to dopamine in the intestine which allows for increased amts of levodopa to reach CNS |
| Action of Dopamine Agonists(Mirapex) | acts directly on dopamine receptors |
| Action of Centrally acting Anticholinergics(Cogentin) | block acetylcholine which maintains balance between dopamine and acetylcholine in brain |
| Action of Antiviral (Symmetrel) | stimulate DA release; prevent DA reuptake; block cholinergic and glutamate receptors |
| Therapeutic Action of Anti-Parkinson’s Med | Don’t stop progression of Parkinsons; but offer relief from dyskinesias |
| Side/Adverse Effects of Anti-Parkinson’s Med | Nausea, drowsiness – admin with food, Dyskinesias (bobbing head, tics),Orthostatic Hypotension, Cardiovascular effects from Beta1 stimulation, Discoloration of sweat/urine |
| Contraindications/precautions of Anti-Parkinson’s Med | Mirapex, malignant melanoma, MAOI, narrow-angle glaucoma |
| Contraindications/precautions of Levodopa | Contraindicated in pt with malignant melanoma, Do use with 2 weeks of MAOI use |
| Contraindications/precautions of Anticholinergic agents | Contraindicated in pt with narrow-angle glaucoma |
| Med/Food Interactions of Levodopa | Proteins interfere with absorption and transport across blood-brain barrier; protein decrease therapeutic effects, Compazine, Pyridoxine, Haldol decrease therapeutic effects; MAOI cause hypertension; Varbidopa increase therapeutic effects |
| Interventions of Anti-Parkinson’s Med | Takes a bit for med to kick in |
| Prototype Medications of Anti-Parkinson’s Med | Dopaminergics - levodopa; Dopamine agonists – Mirapex; Centrally acting anticholinergics – Cogentin; Dopamine releaser – Symmetrel |
| Action of Antipsychotics - Atypical | Blocks serotonin and to a lesser degree dopamine receptors; Also block NE, histamine, and acetylcholine; Reduces positive symptoms, greater reduction of negative symptoms |